Estimation of radiation doses and lifetime attributable risk of radiation-induced cancer in the uterus and prostate from abdomen pelvis CT examinations

被引:6
|
作者
Shubayr, Nasser [1 ]
Alashban, Yazeed [2 ]
机构
[1] Jazan Univ, Coll Appl Med Sci, Dept Diagnost Radiog Technol, Jazan, Saudi Arabia
[2] King Saud Univ, Coll Appl Med Sci, Radiol Sci Dept, Riyadh, Saudi Arabia
关键词
ionizing radiation; cancer incidence; cancer mortality; lifetime attributable risk; computed tomography; uterus; prostate; ATOMIC-BOMB SURVIVORS; COMPUTED-TOMOGRAPHY; MORTALITY; REDUCTION; EMPLOYEES; EXPOSURE; RATES;
D O I
10.3389/fpubh.2022.1094328
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Computed tomography (CT) scans are one of the most common radiation imaging modalities, and CT scans are rising steadily worldwide. CT has the potential to enhance radiography practice, but it also has the risk of drastically increasing patient doses. One CT procedure for the abdomen pelvis (AP) area can expose a patient's prostate or uterus to a substantial radiation dose, leading to concerns about radiation-induced cancer. This study aimed to estimate organ doses of the uterus and prostate and evaluate the lifetime attributable risk (LAR) of cancer incidence and mortality resulting from AP CT examinations. This retrospective study included 665 patients, of which 380 (57%) were female, and 285 (43%) were male. Data were collected from the picture archiving and communication system for AP CT procedures and exposure parameter data. Organ doses for the uterus and prostate were calculated using National Cancer Institute CT (NCICT) software. Based on the risk models proposed by the BEIR VII report, the calculated organ doses were used to estimate the LAR of prostate and uterus cancer incidence and mortality due to radiation exposure from AP CT procedures. The mean effective dose resulting from AP CT for females and males was 5.76 +/- 3.22 (range: 1.13-12.71 mSv) and 4.37 +/- 1.66 mSv (range: 1.36-8.07 mSv), respectively. The mean organ dose to the uterus was 10.86 +/- 6.09 mGy (range: 2.13-24.06 mGy). The mean organ dose to the prostate was 7.00 +/- 2.66 mGy (range: 2.18-12.94 mGy). The LAR of uterus and prostate cancer incidence was 1.75 +/- 1.19 cases and 2.24 +/- 1.06 cases per 100,000 persons, respectively. The LAR of cancer mortality rates from uterus and prostate cancers were 0.36 +/- 0.22 and 0.48 +/- 0.18 cases per 100,000 persons, respectively. The LAR of prostate and uterus cancer occurrence and mortality from radiation doses with AP CT procedures was low but not trivial. Therefore, efforts should be made to lower patient doses while retaining image quality. Although the minimization of the patient's radiation dose must guide clinical practice, the estimated slight increase in risk could aid in easing fears regarding well-justified AP CT procedures.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Estimated Effective Lifetime Risks of Radiation-Induced Thyroid Cancer in (CT) Brain Examination
    Ganesan, Rekha
    Hilal, Muhammad Ikhmal Naim Mohd
    Isa, Iza Nurzawani Che
    Norsuddin, Norhashimah
    Nassir, Khadijah Mohd
    Rahmat, Said Mohd Shaffiq Said
    Abd Karim, Muhammad Khalis
    SAINS MALAYSIANA, 2021, 50 (11): : 3365 - 3372
  • [32] Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis
    Goh, Vicky
    Dattani, Minaxi
    Farwell, Joseph
    Shekhdar, Jane
    Tam, Emily
    Patel, Shilpan
    Juttla, Jaspal
    Simcock, Ian
    Stirling, James
    Mandeville, Henry
    Aird, Edwin
    Hoskin, P.
    EUROPEAN RADIOLOGY, 2011, 21 (05) : 974 - 981
  • [33] Recurrent CT, Cumulative Radiation Exposure, and Associated Radiation-induced Cancer Risks from CT of Adults
    Sodickson, Aaron
    Baeyens, Pieter F.
    Andriole, Katherine P.
    Prevedello, Luciano M.
    Nawfel, Richard D.
    Hanson, Richard
    Khorasani, Ramin
    RADIOLOGY, 2009, 251 (01) : 175 - 184
  • [34] Cumulative radiation doses from recurrent PET-CT examinations
    Hosono, Makoto
    Takenaka, Mamoru
    Monzen, Hajime
    Tamura, Mikoto
    Kudo, Masatoshi
    Nishimura, Yasumasa
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1126):
  • [35] The risk of radiation-induced cancer following VMAT vs. IMPT of prostate cancer
    Stokkevag, C.
    Engeseth, G. M.
    Muren, L. P.
    Ytre-Hauge, K. S.
    Ekanger, C.
    Hysing, L. B.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S472 - S473
  • [36] Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer
    Stokkevag, Camilla H.
    Engeseth, Grete M.
    Hysing, Liv B.
    Ytre-Hauge, Kristian S.
    Ekanger, Christian
    Muren, Ludvig P.
    ACTA ONCOLOGICA, 2015, 54 (09) : 1317 - 1325
  • [37] Estimation of lifetime attributable cancer risk from abdominal-pelvic pediatric CT procedures
    Aloufi, Khalid M.
    JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES, 2025, 18 (01)
  • [38] Risk of Radiation-induced Breast Cancer from Mammographic Screening
    Yaffe, Martin J.
    Mainprize, James G.
    RADIOLOGY, 2011, 258 (01) : 98 - 105
  • [39] THE RISK OF RADIATION-INDUCED CANCER - WHENCE - WHITHER
    SINCLAIR, WK
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1993, 40 (2-3): : 493 - 510
  • [40] Radiation-induced lymphopenia in proton therapy for prostate cancer
    Al-Hamami, Sarah F. A.
    Kurucz, Samuel
    Vondracek, Vladimir
    Pekar, Vladimir
    Kubes, Jiri
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5160 - S5162